Covered recipient · General Payments record
HESSAM AAZAMI
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2018–2024
$15,903.78
- Reported across 468 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $615.83 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $252.21 | 12 |
| Novo Nordisk AS | $193.62 | 5 |
| PFIZER INC. | $63.89 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $46.38 | 2 |
| Acerta Pharma LLC | $23.27 | 1 |
| GlaxoSmithKline, LLC. | $21.73 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $7.40 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117183423 | CMS |
| Amgen Inc. | $32.00 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111507233 | CMS |
| Amgen Inc. | $121.83 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117183433 | CMS |
| Amgen Inc. | $7.77 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111507237 | CMS |
| Amgen Inc. | $10.91 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111507239 | CMS |
| Amgen Inc. | $25.82 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111507235 | CMS |
| Amgen Inc. | $6.22 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117183425 | CMS |
| Amgen Inc. | $11.49 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117183427 | CMS |
| Amgen Inc. | $9.82 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117183429 | CMS |
| Amgen Inc. | $7.00 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117183431 | CMS |
| Amgen Inc. | $5.43 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111507241 | CMS |
| Amgen Inc. | $6.52 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111507243 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.27 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104588916 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.98 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117889652 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.40 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117889654 | CMS |
| GlaxoSmithKline, LLC. | $21.73 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116699283 | CMS |
| Novo Nordisk Inc | $8.16 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097430322 | CMS |
| Novo Nordisk Inc | $17.56 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097187698 | CMS |
| Novo Nordisk Inc | $22.75 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097501175 | CMS |
| Novo Nordisk Inc | $121.82 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097669953 | CMS |
| Novo Nordisk Inc | $23.33 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097173982 | CMS |
| PFIZER INC. | $24.78 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132032552 | CMS |
| PFIZER INC. | $21.37 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131230007 | CMS |
| PFIZER INC. | $17.74 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132001797 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.73 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153599053 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.